The 20 Best Castleman Disease Doctors near Bronx, NY

Amy Sharma , MD, is Co-Director, Hematology Oncology Fellowship Program and Assistant Professor, Hematology Oncology at Montefiore Einstein. Dr. Sharma maintains an active practice focusing on the treatment of sickle cell disease and classical hematology. Dr. Sharma is rated as an Advanced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Non-Hodgkin Lymphoma, Myelofibrosis, Essential Thrombocythemia, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration.

Swati Goel, MBBS, is Leader of the Myeloproliferative Disorder Clinic, Assistant Director of the Hematology-Oncology Fellowship Program and Associate Professor in the Department of Oncology and Medicine at Montefiore Einstein. Her area of clinical focus is myeloproliferative neoplasms, and the conditions she treats include myelofibrosis, polycythemia vera, essential thrombocythemia, mastocytosis, eosinophilia, anemia and pancytopenia. Dr. Goel is rated as an Advanced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Myelofibrosis, Castleman Disease, Multicentric Castleman Disease (MCD), and Unicentric Castleman Disease (UCD).

Fernando J. Camacho, MD, is Assistant Professor, Oncology & Hematology at Montefiore Einstein. He has over 30 years of experience in community oncology and is the former Director of Community Oncology at Montefiore Einstein Center for Cancer Care. This program was established to increase access to preventative and cutting-edge cancer care and research to Bronx and Westchester patients and families and enhance visibility of the Center for Cancer Care through education, outreach and community engagement. Dr. Camacho is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Unicentric Castleman Disease (UCD), Multicentric Castleman Disease (MCD), Castleman Disease, and Richter Syndrome.

"Dr. Joseph Jurcic is a Professor of Medicine at Columbia University Medical Center and the Director of the Hematologic Malignancies Section within the Division of Hematology/Oncology. He specializes in Medical Oncology and focuses on leukemia, myelodysplastic syndromes, and myeloproliferative disorders. Based in New York, NY, Dr. Jurcic is affiliated with NewYork-Presbyterian/Columbia University Irving Medical Center. He received his M.D. from the Perelman School of Medicine at the University of Pennsylvania and completed his training at Barnes-Jewish Hospital and Memorial Sloan Kettering Cancer Center. He is board-certified in both Medical Oncology and Hematology.Dr. Jurcic's clinical expertise includes the treatment of acute and chronic leukemias, myeloproliferative neoplasms, and myelodysplastic syndromes. His research interests encompass acute myeloid leukemia, radioimmunotherapy with alpha and beta particle-emitting radioisotopes, monoclonal antibody therapy, developing novel small molecule inhibitors, and molecular monitoring of minimal residual disease. Recognized as one of New York Magazine's ""Best Doctors"" from 2014 to 2024, he has authored or co-authored over 80 articles and book chapters. He has served as the principal investigator on more than 25 clinical trials. Additionally, Dr. Jurcic lectures at national and international conferences and is the Leukemia Section Editor for The Oncologist.". Dr. Jurcic is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Andrew Eisenberger graduated from Columbia University with a BA in Philosophy in 1992 and received his MD from Albert Einstein College of Medicine in 2001. Dr. Eisenberger did his residency in internal medicine at Montefiore Medical Center, where he served for a year as chief resident. He then completed his fellowship in Hematology/Oncology at New York Presbyterian Hospital/Columbia University Medical Center.Dr. Eisenberger embraces his role as a medical educator: for medical students, physicians in training, colleagues and patients alike. The Columbia University Vagelos School of Physicians and Surgeons’ Hematology course has been under his leadership for more than a decade, and he recently became an associate program director of the University’s Hematology/Oncology post-doctoral fellowship program. Dr. Eisenberger was inducted into the Medical Center’s Academy of Clinic Excellence in 2018. His clinical practice currently focuses on the diagnosis and management of complex bleeding and clotting disorders, particularly in unique populations such as pregnant women and critically ill hospitalized patients. He also has extensive experience with difficult-to-manage blood disorders including antiphospholipid antibody syndrome (APLS), heparin-induced thrombocytopenia (HIT), immune thrombocytopenic purpura (ITP), autoimmune hemolytic anemia (AIHA), thrombotic thrombocytopenic purpura (TTP), hematologic complications of solid organ transplantation and myeloproliferative neoplasms. Dr. Eisenberger is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Myelodysplastic Syndrome (MDS), Thrombocytopenia, Pulmonary Embolism, Thrombectomy, and Splenectomy.

Jennifer Amengual is an Internal Medicine specialist and an Oncologist in New York, New York. Dr. Amengual is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Non-Hodgkin Lymphoma, T-Cell Lymphoma, Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration. Dr. Amengual is currently accepting new patients.

Dr. Raza is a Professor of Medicine and Director of the MDS Center at Columbia University in New York, NY. She started her research in Myelodysplastic Syndromes (MDS) in 1982 and moved to Rush University, Chicago, Illinois in 1992, where she was the Charles Arthur Weaver Professor in Oncology and Director, Division of Myeloid Diseases. The MDS Program, along with a Tissue Repository containing more than 50,000 samples from MDS and acute leukemia patients was successfully relocated to the University of Massachusetts in 2004 and to Columbia University in 2010.Before moving to New York, Dr. Raza was the Chief of Hematology Oncology and the Gladys Smith Martin Professor of Oncology at the University of Massachusetts in Worcester. She has published the results of her laboratory research and clinical trials in prestigious, peer-reviewed journals such as The New England Journal of Medicine, Nature, Blood, Cancer, Cancer Research, the British Journal of Hematology, Leukemia, and Leukemia Research. Dr. Raza serves on numerous national and international panels as a reviewer, consultant, and advisor and is the recipient of a number of awards. Dr. Raza is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Leukemia.

John Mascarenhas is an Oncologist in New York, New York. Dr. Mascarenhas is rated as a Distinguished provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Myelofibrosis, Polycythemia Vera, Myeloproliferative Neoplasms (MPN), Bone Marrow Aspiration, and Splenectomy. Dr. Mascarenhas is currently accepting new patients.

Ronald Hoffman is an Oncologist in New York, New York. Dr. Hoffman is rated as a Distinguished provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Polycythemia Vera, Myelofibrosis, Essential Thrombocythemia, Splenectomy, and Bone Marrow Transplant.

Marina Kremyanskaya is an Oncologist in New York, New York. Dr. Kremyanskaya is rated as a Distinguished provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia, Bone Marrow Aspiration, and Splenectomy. Dr. Kremyanskaya is currently accepting new patients.

Ariela Noy is a Hematologist and an Oncologist in New York, New York. Dr. Noy is rated as a Distinguished provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Non-Hodgkin Lymphoma, Burkitt Lymphoma, Marginal Zone Lymphoma (MZL), Bone Marrow Transplant, and Tissue Biopsy. Dr. Noy is currently accepting new patients.

Ghaith Abu is a Hematologist and an Oncologist in New York, New York. Dr. Abu is rated as a Distinguished provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Unicentric Castleman Disease (UCD), Multicentric Castleman Disease (MCD), Castleman Disease, and Polycythemia Vera. Dr. Abu is currently accepting new patients.

Javier Roca is a Hematologist and an Oncologist in Rego Park, New York. Dr. Roca is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Malabsorption, Myelodysplastic Syndrome (MDS), Vitamin B12 Deficiency, and Blood Clots.

Thanh-ha Luong is a Hematologist in Bronx, New York. Dr. Luong is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Thalassemia, and Anemia.

Leon Landau is a Hematologist in Bronx, New York. Dr. Landau is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Polycythemia Vera, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Hemangioma Thrombocytopenia Syndrome, and Thrombocytopenia.

Pamela Drullinsky is an Oncologist in New York, New York. Dr. Drullinsky is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Breast Cancer, Non-Hodgkin Lymphoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Drullinsky is currently accepting new patients.

Gail Roboz is a Hematologist and an Oncologist in New York, New York. Dr. Roboz is rated as an Advanced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Roboz is currently accepting new patients.

Richard Furman is an Oncologist in New York, New York. Dr. Furman is rated as an Advanced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Bone Marrow Aspiration, and Lymphadenectomy. Dr. Furman is currently accepting new patients.

Lori Leslie is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Leslie is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Lymphadenectomy.

Michele Donato is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Donato is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Multiple Myeloma, Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Colonoscopy.